Literature DB >> 27922533

A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent.

Rishi J Desai1, Kenneth J Rothman, Brian T Bateman, Sonia Hernandez-Diaz, Krista F Huybrechts.   

Abstract

BACKGROUND: When exposure is infrequent, propensity-score matching results in reduced precision because it discards a large proportion of unexposed patients. To our knowledge, the relative performance of propensity-score stratification in these circumstances has not been examined.
METHODS: Using an empirical example of the association of first trimester statin exposure (prevalence = 0.04%) with risk of congenital malformations and 1,000 simulated cohorts (n = 20,000) with eight combinations of exposure prevalence (0.5%, 1%, 5%, 10%) and outcome risk (3.5%, 10%), we compared four propensity-score-based approaches to confounding adjustment: (1) matching (1:1, 1:5, full), (2) stratification in 10, 50, and 100 strata by entire cohort propensity-score distribution, (3) stratification in 10, 50, and 100 strata by exposed group propensity-score distribution, (4) standardized mortality ratio (SMR) weighting. Weighted generalized linear models were used to derive effect estimates after weighting unexposed according to the distribution of the exposed in their stratum for the stratification approaches.
RESULTS: In the empirical example, propensity-score stratification (cohort) approaches resulted in greater imbalances in covariate distributions between statin-exposed and unexposed compared with propensity-score stratification (exposed) and matching. In simulations, propensity-score stratification (exposed) resulted in smaller relative bias than the cohort approach with 10 and 50 strata, and greater precision than matching and SMR weighting at 0.5% and 1% exposure prevalence, but similar performance at 5% and 10%.
CONCLUSION: For exposures with prevalence under 5%, propensity-score stratification with fine strata, based on the exposed group propensity-score distribution, produced the best results. For more common exposures, all approaches were equivalent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27922533      PMCID: PMC5497217          DOI: 10.1097/EDE.0000000000000595

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  18 in total

1.  Substantial gains in bias reduction from matching with a variable number of controls.

Authors:  K Ming; P R Rosenbaum
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Low P-values or narrow confidence intervals: which are more durable?

Authors:  C Poole
Journal:  Epidemiology       Date:  2001-05       Impact factor: 4.822

3.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

4.  A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use.

Authors:  Peter C Austin; Muhammad M Mamdani
Journal:  Stat Med       Date:  2006-06-30       Impact factor: 2.373

5.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

Review 6.  Indications for propensity scores and review of their use in pharmacoepidemiology.

Authors:  Robert J Glynn; Sebastian Schneeweiss; Til Stürmer
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

7.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

8.  The effectiveness of adjustment by subclassification in removing bias in observational studies.

Authors:  W G Cochran
Journal:  Biometrics       Date:  1968-06       Impact factor: 2.571

9.  One-to-many propensity score matching in cohort studies.

Authors:  Jeremy A Rassen; Abhi A Shelat; Jessica Myers; Robert J Glynn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05       Impact factor: 2.890

10.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17
View more
  53 in total

1.  Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.

Authors:  Yoonyoung Park; Sonia Hernandez-Diaz; Brian T Bateman; Jacqueline M Cohen; Rishi J Desai; Elisabetta Patorno; Robert J Glynn; Lee S Cohen; Helen Mogun; Krista F Huybrechts
Journal:  Am J Psychiatry       Date:  2018-05-07       Impact factor: 18.112

2.  Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study.

Authors:  Rishi J Desai; Joshua J Gagne; Joyce Lii; Jun Liu; Sonia Friedman; Seoyoung C Kim
Journal:  CMAJ       Date:  2017-11-27       Impact factor: 8.262

3.  Lithium Use in Pregnancy and the Risk of Cardiac Malformations.

Authors:  Elisabetta Patorno; Krista F Huybrechts; Brian T Bateman; Jacqueline M Cohen; Rishi J Desai; Helen Mogun; Lee S Cohen; Sonia Hernandez-Diaz
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

4.  Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology.

Authors:  John E Ripollone; Krista F Huybrechts; Kenneth J Rothman; Ryan E Ferguson; Jessica M Franklin
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

5.  Pregabalin use early in pregnancy and the risk of major congenital malformations.

Authors:  Elisabetta Patorno; Brian T Bateman; Krista F Huybrechts; Sarah C MacDonald; Jacqueline M Cohen; Rishi J Desai; Alice Panchaud; Helen Mogun; Page B Pennell; Sonia Hernandez-Diaz
Journal:  Neurology       Date:  2017-04-26       Impact factor: 9.910

6.  Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort Study.

Authors:  Hemin Lee; Yinzhu Jin; Miin Roh; Theodore N Tsacogianis; Sangshin Park; Nam-Kyong Choi; Seoyoung C Kim
Journal:  Drugs Aging       Date:  2020-04       Impact factor: 3.923

7.  Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.

Authors:  Krista F Huybrechts; Sonia Hernandez-Diaz; Loreen Straub; Kathryn J Gray; Yanmin Zhu; Helen Mogun; Brian T Bateman
Journal:  JAMA       Date:  2020-01-28       Impact factor: 56.272

8.  Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections.

Authors:  Joe Amoah; Elizabeth A Stuart; Sara E Cosgrove; Anthony D Harris; Jennifer H Han; Ebbing Lautenbach; Pranita D Tamma
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

Authors:  Julia Spoendlin; Julie M Paik; T Tsacogianis; Seoyoung C Kim; Sebastian Schneeweiss; Rishi J Desai
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

Review 10.  Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research.

Authors:  Jeff Y Yang; Michael Webster-Clark; Jennifer L Lund; Robert S Sandler; Evan S Dellon; Til Stürmer
Journal:  Gastrointest Endosc       Date:  2019-04-30       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.